Redefining clinical trial strategic design to support drug approval in medical oncology.
- DOI
- 10.1016/j.annonc.2025.03.005
- Published
- 2025-03-12
- Container
- Ann Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2025.03.005,
title = {Redefining clinical trial strategic design to support drug approval in medical oncology.},
author = {Antonarelli G and Pérez-García JM and Gion M and Rugo H and Schmid P and Bardia A and Hurvitz S and Harbeck N and Tolaney SM and Curigliano G and Llombart-Cussac A and Cortés J.},
year = {2025},
journal = {Ann Oncol},
doi = {10.1016/j.annonc.2025.03.005},
url = {https://doi.org/10.1016/j.annonc.2025.03.005}
}RIS
TY - JOUR TI - Redefining clinical trial strategic design to support drug approval in medical oncology. AU - Antonarelli G AU - Pérez-García JM AU - Gion M AU - Rugo H AU - Schmid P AU - Bardia A AU - Hurvitz S AU - Harbeck N AU - Tolaney SM AU - Curigliano G AU - Llombart-Cussac A AU - Cortés J. PY - 2025 JO - Ann Oncol DO - 10.1016/j.annonc.2025.03.005 UR - https://doi.org/10.1016/j.annonc.2025.03.005 ER -
APA
G, A., JM, P., M, G., H, R., P, S., A, B., S, H., N, H., SM, T., G, C., A, L., & J., C. (2025). Redefining clinical trial strategic design to support drug approval in medical oncology.. Ann Oncol. https://doi.org/10.1016/j.annonc.2025.03.005
Source records
- europe-pmc · retrieved 2026-09-26T01:41:30.629Z